Characteristics of a Compounder
Webinar Description: Join Chris White Head of Research at 5i Research outlines...
New Issues
While it is easy to abandon an asset class with a mention of the dreaded word “bubble” or such drawdowns, we think there is a lot...
Bonds have seen dormant popularity over the past decade and with rising rates, bonds are becoming even less attractive. Equities, on the other...
Since the beginning of 2022, there has been an uninterrupted sequence of bad news. The current headlines are all about the three Rs: recession,...
Check out the refreshed website and new features!
Neighbourly Pharmacy (NBLY) chain, Canada’s third-largest pharmacy chain operator, has filed preliminary documents for a $150 million...
About four months into the year, if we were forced to pronounce an investment ‘theme’ for 2021, it would probably be that of...
One of the stocks that our company follows got attacked this week. That’s right, Well Technologies (WELL on TSX) was the subject of not one,...
Looking for more? Sign up for a FREE 14 day trial! No credit card required
We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!
More from 5i Research
5i Stock Screener: Canadian Dividend Growth Machines as a Defensive Play
2025 should be another solid year for the market. Both the S&P 500 and TSX performed...
Rockets and Duds: Week 42 - October 20, 2025
5i Research Weekly Rockets and Duds Last week was rougher-than-usual in the stock...